Christian Sillaber

8.9k total citations · 2 hit papers
147 papers, 6.7k citations indexed

About

Christian Sillaber is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Christian Sillaber has authored 147 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Hematology, 54 papers in Immunology and 40 papers in Genetics. Recurrent topics in Christian Sillaber's work include Mast cells and histamine (48 papers), Chronic Myeloid Leukemia Treatments (47 papers) and Eosinophilic Disorders and Syndromes (33 papers). Christian Sillaber is often cited by papers focused on Mast cells and histamine (48 papers), Chronic Myeloid Leukemia Treatments (47 papers) and Eosinophilic Disorders and Syndromes (33 papers). Christian Sillaber collaborates with scholars based in Austria, United States and Germany. Christian Sillaber's co-authors include Peter Valent, Matthias Mayerhofer, Wolfgang R. Sperr, Klaus Lechner, Peter Bettelheim, Karl J. Aichberger, Dietrich Kraft, Rudolf Valenta, Michael Duchêne and James D. Griffin and has published in prestigious journals such as Science, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Christian Sillaber

141 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of Profilin as a Novel Pollen Allergen; IgE Autoreactivity in Sensitized Individuals

1991 526 citations Rudolf Valenta, Christian Sillaber et al. profile →
Profilins constitute a novel family of functional plant pan-allergens.

1992 515 citations Rudolf Valenta, Peter Valent et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christian Sillaber Austria	46	2.3k	1.9k	1.7k	1.5k	1.3k	147	6.7k
Stefan Karlsson Sweden	60	2.5k 1.1×	2.2k 1.2×	8.3k 4.8×	613 0.4×	1.4k 1.0×	196	13.9k
Andreas Reiter Germany	52	1.6k 0.7×	4.0k 2.1×	2.8k 1.6×	173 0.1×	3.4k 2.5×	278	8.8k
David M. Hilbert United States	31	3.1k 1.4×	477 0.3×	1.2k 0.7×	170 0.1×	423 0.3×	73	6.5k
Eva C. Guinan United States	39	1.5k 0.6×	2.1k 1.1×	1.3k 0.8×	202 0.1×	1.5k 1.1×	135	6.4k
Asim Khwaja United Kingdom	38	1.4k 0.6×	1.8k 1.0×	4.0k 2.3×	549 0.4×	655 0.5×	118	6.9k
Shikha Bose United States	43	757 0.3×	429 0.2×	6.3k 3.6×	177 0.1×	923 0.7×	109	10.2k
Lene Nielsen Denmark	37	512 0.2×	2.9k 1.6×	1.8k 1.1×	1.4k 0.9×	547 0.4×	96	7.3k
Martin Carroll United States	49	1.8k 0.8×	4.7k 2.5×	6.8k 3.9×	87 0.1×	2.1k 1.6×	200	11.7k
Joffre Baker United States	38	832 0.4×	1.2k 0.7×	4.5k 2.6×	589 0.4×	436 0.3×	68	12.1k
Dan Jones United States	51	1.1k 0.5×	4.6k 2.5×	1.7k 1.0×	44 0.0×	4.0k 3.0×	256	8.6k

Countries citing papers authored by Christian Sillaber

Since Specialization

Citations

This map shows the geographic impact of Christian Sillaber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christian Sillaber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christian Sillaber more than expected).

Fields of papers citing papers by Christian Sillaber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christian Sillaber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christian Sillaber. The network helps show where Christian Sillaber may publish in the future.

Co-authorship network of co-authors of Christian Sillaber

This figure shows the co-authorship network connecting the top 25 collaborators of Christian Sillaber. A scholar is included among the top collaborators of Christian Sillaber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christian Sillaber. Christian Sillaber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thalhammer, Renate, Christian Sillaber, Ulla Derhaschnig, et al.. (2024). Very low doses of rituximab in autoimmune hemolytic anemia—an open-label, phase II pilot trial. Frontiers in Medicine. 11. 1481333–1481333. 2 indexed citations

Treiblmaier, Horst & Christian Sillaber. (2021). The impact of blockchain on e-commerce: A framework for salient research topics. Electronic Commerce Research and Applications. 48. 101054–101054. 111 indexed citations

Sillaber, Christian, et al.. (2020). DLT-Handelssysteme. Eine Einordnung in das Zivil- und Aufsichtsrecht. Bern Open Repository and Information System (University of Bern).

Sillaber, Christian, Bernhard Waltl, Horst Treiblmaier, Ulrich Gallersdörfer, & Michael Felderer. (2020). Laying the foundation for smart contract development: an integrated engineering process model. Information Systems and e-Business Management. 19(3). 863–882. 23 indexed citations

Sillaber, Christian, et al.. (2018). Towards data-driven decision support for organizational IT security audits. it - Information Technology. 60(4). 207–217. 3 indexed citations

Sauerwein, Clemens, et al.. (2017). Threat Intelligence Sharing Platforms: An Exploratory Study of Software Vendors and Research Perspectives. Journal of the Association for Information Systems. 67 indexed citations

Mayerhoefer, Marius E., Georgios Karanikas, Kurt Kletter, et al.. (2015). Evaluation of Diffusion-Weighted Magnetic Resonance Imaging for Follow-up and Treatment Response Assessment of Lymphoma: Results of an 18F-FDG-PET/CT–Controlled Prospective Study in 64 Patients. Clinical Cancer Research. 21(11). 2506–2513. 66 indexed citations

Sillaber, Christian & Ruth Breu. (2015). Using Business Process Model Awareness to improve Stakeholder Participation in Information Systems Security Risk Management Processes. Journal of the Association for Information Systems. 1177–1190. 3 indexed citations

Mayerhoefer, Marius E., Georgios Karanikas, Kurt Kletter, et al.. (2014). Evaluation of Diffusion-Weighted MRI for Pretherapeutic Assessment and Staging of Lymphoma: Results of a Prospective Study in 140 Patients. Clinical Cancer Research. 20(11). 2984–2993. 81 indexed citations

10.

Einwallner, Elisa, Gerlinde Mitterbauer‐Hohendanner, Martin Bilban, et al.. (2013). Endogenous Erythroid Colony Formation in Chronic Myeloid Leukemia: A Recurrent Finding Associated with Persistent Minimal Residual Disease Under Imatinib. Stem Cells and Development. 22(23). 3043–3051. 1 indexed citations

11.

Sillaber, Christian & Ruth Breu. (2012). Managing legal compliance through security requirements across service provider chains: A case study on the German Federal Data Protection Act.. GI-Jahrestagung. 1306–1317. 2 indexed citations

12.

Gleixner, Karoline V., Barbara Peter, Alexander Gruze, et al.. (2010). Polo-like Kinase 1 (Plk1) as a Novel Drug Target in Chronic Myeloid Leukemia: Overriding Imatinib Resistance with the Plk1 Inhibitor BI 2536. Cancer Research. 70(4). 1513–1523. 74 indexed citations

13.

Baumgärtner, Christian, Sabine Cerny‐Reiterer, Karoline Sonneck, et al.. (2009). Expression of Activated STAT5 in Neoplastic Mast Cells in Systemic Mastocytosis. American Journal Of Pathology. 175(6). 2416–2429. 60 indexed citations

14.

Aichberger, Karl J., Karoline V. Gleixner, Irina Mirkina, et al.. (2009). Identification of proapoptotic Bim as a tumor suppressor in neoplastic mast cells: role of KIT D816V and effects of various targeted drugs. Blood. 114(26). 5342–5351. 58 indexed citations

15.

Mayerhofer, Matthias, Karoline V. Gleixner, Andrea Hoelbl‐Kovacic, et al.. (2008). Unique Effects of KIT D816V in BaF3 Cells: Induction of Cluster Formation, Histamine Synthesis, and Early Mast Cell Differentiation Antigens. The Journal of Immunology. 180(8). 5466–5476. 58 indexed citations

16.

Vales, Anja, Rudin Kondo, Karl J. Aichberger, et al.. (2007). Myeloid leukemias express a broad spectrum of VEGF receptors including neuropilin-1 (NRP-1) and NRP-2. Leukemia & lymphoma. 48(10). 1997–2007. 31 indexed citations

17.

Lechner, Klaus, Manuela Födinger, Wolfgang Grisold, Andreas Püspök, & Christian Sillaber. (2005). Vitamin B12 deficiency: New data on an old disease. Wiener klinische Wochenschrift. 117(17). 579–591. 14 indexed citations

18.

Mayerhofer, Matthias, Karl J. Aichberger, Stefan Florian, et al.. (2005). Identification of mTOR as a novel bifunctional target in chronic myeloid leukemia: dissection of growth‐inhibitory and VEGF‐suppressive effects of rapamycin in leukemic cells. The FASEB Journal. 19(8). 960–962. 51 indexed citations

19.

Agis, Hermine, Waltraud J. Beil, Hans Bankl, et al.. (1996). Mast Cell-Lineage Versus Basophil Lineage Involvement in Myeloproliferative and Myelodysplastic Syndromes: Diagnostic Role of Cell-Immunopheno typing. Leukemia & lymphoma. 22(3-4). 187–204. 34 indexed citations

20.

Sillaber, Christian, Dorian Bevec, Joseph H. Butterfield, et al.. (1993). Tumor necrosis factor alpha and interleukin-1 beta mRNA expression in HMC-1 cells: differential regulation of gene product expression by recombinant interleukin-4.. PubMed. 21(9). 1271–5. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact